Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157 ORAL Beverly Hills Rejuvenation Center The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks FDA Compliance for Peptide Therapy and BPC 157 Holt Law